Skip to Main ContentSkip to FooterSkip to Search
Main menu
  1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Development & Bioavailability
  6.  » Dose Selection Using Preclinical PK Modeling
Webinar icon

Dose Selection Using Preclinical PK Modeling and In Vivo Studies

Summary: The main goal of formulation and dosage form development is to modify the pharmacokinetics of drugs to improve efficacy and safety. This goal is achieved through various means such as improving solubility and bioavailability and targeting drug release at a specific rate or at a specific site in the gut.  This webinar introduces the audience to pre-clinical tools used in the industry to study pharmacokinetics and how they are used to guide the development of new chemical entities (NCEs).

Click here to download webinar